Study
Early Alzheimer’s Study
Study participation helps move research forward.
Join an early-Alzheimer's study.
This study looks at an oral medication that’s taken once a day, making it an easier and more convenient option for many people.
The purpose of this early-Alzheimer’s study is to find out if the study drug can possibly prevent, delay, or slow early symptoms of Alzheimer’s disease. It is thought this new investigational drug may help the blood vessels in your brain work better by increasing blood flow to the brain, reducing inflammation, and possibly curtailing amyloid protein production, a major biomarker for Alzheimer’s.
READ MORE ABOUT THIS STUDY |
Who is eligible?
You may qualify for this study if:
- You are 50-90 years of age.
- You have mild cognitive impairment or mild dementia consistent with Alzheimer's disease, but can complete most daily tasks independently.
Sign Up
Schedule Your Assessment
Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.
Get More Information
Locations supporting this study
-
Orlando
1724 N. Mills Avenue, Suite 200Orlando, FL 32803Hours of Operation
Monday thru Friday
8am to 5pm -
The Villages
1025 Lake Sumter LandingThe Villages, FL 32162Hours of Operation
Monday thru Friday
8am to 5pmContact